ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
{{output}}
Cancer immunotherapy has transformed treatment possibilities, but its effectiveness differs significantly among patients, indicating the presence of alternative pathways for immune evasion. Here, we show that ITPRIPL1 functions as an inhibitory ligand of CD3ε... ...
